Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$485,540,134
+$44,491,511 QoQ
Shares Held
1,929,503
-4.9% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#83
of 4,138 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NEW YORK STATE COMMON RETIREMENT FUND holds $3,404,819,993 across 17 Drug Manufacturers - General names. ABBV ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
865,587 | $1,038,211,101 | |
| 2 | JNJ |
Johnson & Johnson
|
2,843,846 | $722,251,568 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,929,503 | $485,540,134 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,909,819 | $373,911,741 | |
| 5 | AMGN |
Amgen Inc
|
592,725 | $214,637,577 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,360,670 | $171,907,047 | |
| 7 | PFE |
Pfizer Inc
|
6,662,243 | $160,426,811 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,244,020 | $129,300,432 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $485,540,134 | 1,929,503 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $441,048,623 | 2,027,903 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $462,807,180 | 2,025,503 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $476,895,991 | 2,059,670 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $406,316,611 | 2,188,970 | Shares | Sole | 2025-10-08 | |
| 2025-03-31 | $463,305,290 | 2,211,270 | Shares | Sole | 2025-10-08 | |
| 2024-12-31 | $395,248,514 | 2,224,246 | Shares | Sole | 2025-10-08 | |
| 2024-09-30 | $438,414,684 | 2,220,046 | Shares | Sole | 2025-10-08 | |
| 2024-06-30 | $404,659,589 | 2,359,256 | Shares | Sole | 2025-10-08 | |
| 2024-03-31 | $436,557,252 | 2,397,349 | Shares | Sole | 2025-10-08 | |
| 2023-12-31 | $391,847,688 | 2,528,539 | Shares | Sole | 2025-10-08 | |
| 2023-09-30 | $407,830,544 | 2,736,016 | Shares | Sole | 2025-10-08 | |
| 2023-06-30 | $390,609,620 | 2,899,203 | Shares | Sole | 2025-10-08 | |
| 2023-03-31 | $473,009,203 | 2,967,994 | Shares | Sole | 2025-10-08 | |
| 2022-12-31 | $542,180,217 | 3,354,868 | Shares | Sole | 2025-10-08 | |
| 2022-09-30 | $449,373,866 | 3,348,289 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $534,803,322 | 3,491,795 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $573,729,336 | 3,539,136 | Shares | Sole | 2022-07-01 | |
| 2021-12-31 | $478,930,787 | 3,537,155 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $383,306,660 | 3,553,413 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $427,638,097 | 3,796,503 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $419,032,385 | 3,872,042 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $409,301,534 | 3,819,893 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $334,653,186 | 3,820,678 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $392,736,494 | 4,000,168 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $257,215,687 | 3,375,977 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||